phenylalanine at position 508. This mutation is responsible for approximately 70% of CF alleles. 5 The DF508 mutation impairs CFTR's ability to exit the endoplasmic reticulum, reducing expression at the cell surface. 10 Channels that do make it to the surface open less frequently. A person who is homozygous for the DF508 mutation has very little channel activity and subsequently a severe disease phenotype.
11
Distinguishing features of CF is complex and include salty skin, poor growth, intestinal obstruction and malabsorption, infertility, pancreatic insufficiency, frequent airway infection and inflammation, persistent coughing, adherent and viscous mucus, and difficulty breathing. 1, 12 Respiratory disease is the major cause of mortality and morbidity in people with CF. 13 Decades of work suggest that a lack of bicarbonate and chloride transport across epithelia is the cause of CF pathogenesis. [14] [15] [16] [17] [18] [19] [20] Those studies are reviewed elsewhere and will not be reviewed here. 12, [21] [22] [23] [24] [25] Managing CF often requires individualized treatment and care. Current treatments targeting the CF airway include mucolytic agents, chest physiotherapy, antiviral agents, antibiotics, antiinflammatory drugs, bronchodilators, and lung transplantation. 26, 27 Small-molecule therapies that target CFTR mutations have also become available recently and have shown great success. [27] [28] [29] Several institutions continue to pursue gene therapy to correct and restore normal CFTR function [30] [31] [32] [33] 
CFTR Expression and Function in the Nervous System
Expression of CFTR is developmentally regulated and widespread. [34] [35] [36] [37] Although expression in epithelial cells has been studied most, immune cells, 38 49 Expression of CFTR in the nervous system is particularly intriguing because chloride transport is a well-known modulator of neuronal activity. 50 In addition, as highlighted further on, many of the features of CF could manifest due to nervous system dysfunction. McGrath et al 40 were the first to describe CFTR in the nervous system. Subsequent studies by Mulberg et al 51, 52 detailed CFTR expression in the rat brain (Fig 1) . The expression pattern of CFTR suggested a possible role in regulation of mood and memory, energy homeostasis, olfaction, motor function, respiration, and autonomic control of visceral organs. 51, 52 Additional studies found CFTR expression or activity (or both) in rodent dorsal root ganglion neurons, 53 hypothalamic neurons, 54 and motor neurons. 37 In pigs, CFTR is expressed in both the peripheral and central nervous systems. 55, 56 In humans, CFTR has been identified in parvocellular ganglion, 57 hypothalamic neurons, 58 spinal cord neurons, 59 ganglion cells of the heart, 60 and sympathetic ganglion. 61 Both neuronal and glial cell CFTR expression has been reported in multiple species, 55, [62] [63] [64] with the exception of humans, in whom only neuronal CFTR has been reported. 48, 54 The function of CFTR in the nervous system is uncertain. Reports of CFTR in the hypothalamus sparked speculations that neural CFTR may be important in maintenance of the neuroendocrine Figure 1 -CFTR in the rat brain. Summary of work by Mulberg et al 51, 52 showing CFTR expression (yellow) in the rat brain. Location suggests involvement in energy homeostasis, limbic function, olfaction, motor function, respiration, and autonomic regulation of numerous effector organs, including the airways, GI tract, and heart. Amy axis. 51, 52, 58 Indeed, decreasing CFTR expression in a rat hypothalamic cell line reduced the release of gonadotropin-releasing hormone. 54 In an additional study, the responsivity of glucose-sensitive neurons in the rat hypothalamus decreased with pharmacologic inhibition of CFTR. 65 Our studies in newborn pigs revealed CFTR mRNA in the pituitary and hypothalamus and demonstrated that release of growth hormone is reduced in pituitary slice cultures isolated from CF pigs compared with non-CF littermates. 56 These studies are all consistent with a function of CFTR in modulating the neuroendocrine axis.
A nonneuroendocrine function of CFTR has also been proposed. Ostroumov et al 37 used CFTR inhibitors and computer modeling to demonstrate that CFTR modifies the excitability of motor neurons in the rat spinal cord. The authors went on to speculate that exaggerated neuronal excitability in individuals with CF might contribute to an increased incidence of seizures following lung transplantation. 66 A role for CFTR in modulating ATP release from dorsal root ganglion neurons was reported. 53 Given the important role of ATP in pain responses, it is possible that CFTR in the dorsal root ganglia might modify nociception. 67, 68 An additional set of experiments by Liu et al 63 suggested
that microglia isolated from CF mice release less ATP. 63 The implications from this study were that lack of CFTR decreases propagation of calcium waves in microglia, which in turn affects the extension and retraction of microglial processes. The extension and retraction of microglial processes plays an important role in the scavenging of damaged brain tissue. 69 Another study found no obvious role for CFTR in modulating glial cell activity. 64 
Neural Abnormalities in Cystic Fibrosis
Given that CFTR is expressed and functional in the nervous system, it is not surprising that several nervous system abnormalities have been reported in CF.
Although it is not known whether these abnormalities are primary or secondary or the extent to which they are manifested in all people with CF, their presence may be a component of, or may contribute to, pathogenesis, or both. Following is a brief summary of selected anomalies.
Innervation
Alterations in neural innervation have been repeatedly reported in CF (Table 1) . Heinz-Erian et al 70 were first to describe reduced innervation of the sweat gland in humans with CF. The authors suggested that the reduced innervation of the sweat gland might contribute to the high salt content of sweat in people with CF. A subsequent study also found that cutaneous innervation was decreased in humans with CF. 71 Pan et al 72 described decreased innervation of the CF mouse airway in utero that persisted postnatally. The decreased innervation was associated with decreased smooth muscle mass and decreased pulmonary neuroendocrine cells. Interestingly, in humans with CF, the number of pulmonary neuroendocrine cells is elevated. 73, 74 Our studies in the pig suggest that innervation of the sinuses 55 and trachea 75 is also decreased. 
Ventilatory Responses
Abnormalities in ventilation have also been reported in CF. In mice, the ventilatory response to hypoxia is decreased. 83 In people with CF, ventilatory responses to hypoxia are also reduced, 84 whereas exercise causes an exaggerated ventilatory response. 85 Since CF mice do not exhibit lung infections like humans, it seems less likely that a decreased ventilatory response is explained by airway infection or inflammation. Because ventilatory responses involve neural control of both pulmonary and cardiac systems, one interpretation of these findings is that people with CF have dysregulation of the neural cardiopulmonary reflexes. Other factors, such as reduced lung compliance, might also contribute. 86 
Autonomic Function
Several studies suggest that autonomic function is altered in people with CF. Davis Human "þ" means there are data to support the finding that the innervation or function is affected in CF. References listed directly support the finding that either innervation or bodily function controlled by the nervous system is affected in CF. CF ¼ cystic fibrosis. nervous system-mediated response and is also exaggerated in people with CF. [91] [92] [93] Alterations in smooth muscle contractile responses to cholinergic agonists have also been described, 45, 94 as has abnormal heart rate variability. 79, 80 Altered autonomic function could contribute to manifestations of CF, including cough, GI motility, and mucus secretion, topics explored in greater detail further on.
Possible Neural Contributions to CF Pathogenesis
The nervous system exerts widespread control of multiple organs, including those affected in CF (Fig 2) . Thus it is possible that nervous system defects could contribute to CF pathogenesis (Fig 3) . Select categories of CF features that might be modified by or attributed to (or both) nervous system dysfunction are discussed in the following sections. Additional features are highlighted in Table 1 . The following sections are speculative due to limited literature and a lack of clinical studies focused on the nervous system. They are also intentionally brief to minimize diluting relevant points and concepts.
Cough
Cough is a protective behavior mediated by the nerves innervating the airway. 95 The presumed triggers for cough are viscous and adherent mucus, impaired Figure 3 -Potential mechanism for how loss of CFTR might affect neuronal function and contribute to pathogenesis. Peripheral neurons participate in the detection of irritants and generation of protective reflexes, such as cough. The information is sent to central neurons in the brainstem to cause efferent release of acetylcholine, causing smooth muscle contraction and mucus secretion. In peripheral neurons, chloride (Cl -) currents are excitatory; therefore, loss of CFTR might decrease peripheral neuron activity. In central neurons, chloride currents are generally inhibitory, and therefore loss of CFTR might enhance central neuron activity. Inset shows hypothetical activation of CFTR by agents that raise intracellular cyclic adenosine monophosphate (cAMP) and predicted outcome on neuronal activity in the absence of CFTR. The asterisks (*) and text identify functions carried out by specific nerves innervating the airway. The nodose and jugular ganglia house sensory neurons that innervate the airway. The dashed line distinguishes central vs peripheral nervous system. It should be noted that the vagus nerve innervates many organs, including the GI tract and pancreas.
journal.publications.chestnet.org mucociliary transport, and chronic airway infection and inflammation. 96 110 Thus, it is possible that in CF, the neural circuits mediating submucosal gland secretion are abnormal.
Glucose Regulation
Cystic fibrosis-related diabetes (CFRD) is one of the most common comorbidities in people with CF.
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CFRD is associated with more frequent pulmonary exacerbations, 112 more severe lung disease, 113 and greater mortality. 114 Prior to the development of overt diabetes, people with CF display a spectrum of glucose tolerance abnormalities. 115 Similar observations have been made in CF animal models. 76, 116 Over time, insulin deficiency and insulin resistance develop. CFTR has been found in key neural regions, such as the hypothalamus and sympathetic nervous system, 56, 58, 61 that exert control over the allocation of glucose and endocrine pancreatic function. 117 In the hypothalamus, diminished CFTR activity impairs neuronal glucosesensing properties. 65 Decreased neuronal glucosesensing in specific subregions of the hypothalamus induces glucose intolerance and deficient insulin secretion. 118 Thus, it is possible that defects in the neural mechanisms governing endocrine pancreatic function and glucose regulation contribute to CFRD.
Conclusions
CF is a complex disease that affects many organs. Although the nervous system is not traditionally viewed as an organ affected in CF, limited evidence suggests that it is impacted and might contribute to CF pathogenesis. It is well accepted that chloride transport greatly modifies neuronal activity. 50 Thus it is predicted that the presence or absence of CFTR within the nervous system might influence neuronal function. Yet little is known regarding the role of CFTR in the nervous system or how the nervous system might contribute to CF. Further investigations that focus on neural CFTR in clinically relevant phenotypes, such as cough, GI obstruction, mucus abnormalities, and glucose regulation, are of considerable interest. The use of animal models with conditional CFTR expression might be of particular value in this regard. Alternatively, selective rescue of CFTR to distinct neural subcompartments might also yield significant information. Clinical assessment of the effects of CFTR potentiators and correctors on neural function in people with CF might also be highly interesting. Such studies might embrace noninvasive measurements of neural function, including auditory brainstem-evoked potentials, pupillary reflex, and aquagenic wrinkling. Carrying out any one of these lines of work might reveal new knowledge and unanticipated insight into CF pathogenesis.
